Hani S. Zaki has been appointed vice president and general manager of Periapproval Services for Covance, Inc. Mr. Zaki will be responsible for managing large research studies on the use of pharmaceuticals in real world clinical practice.
Prior to coming to Covance Mr. Zaki was with PharmaNet for nine years where he served as vice president of business development, leading the company's global efforts to build its Phase IIIb and Phase IV research business. Prior to joining PharmaNet, Mr. Zaki spent more than 16 years working in both clinical research and commercial roles on the client side. After early career experience in data management at Schering-Plough and in clinical operations with Bristol-Myers, Mr. Zaki was with Rhone-Poulenc Rorer (RPR, now sanofi-aventis) where he headed the U.S. anti-infective clinical operations group. While at RPR, he was also a part of Dermik Laboratories' licensing and market development group with sales & marketing responsibilities for several ex-U.S. markets.
"The market for Periapproval Services is likely to accelerate further as manufacturers seek to optimize sales of their in-line products and regulatory changes prompt a heightened need for safety studies," said Luis Gutierrez, president of Covance Commercialization Services. "Mr. Zaki's depth of experience and track record identifying and developing new business opportunities will help to expand our efforts to maximize the delivery of integrated service offerings to our clients and our overall share of this growing market," he added.